News

Dr Halpern was most recently director of regulatory affairs and head of technical regulatory affairs, North America for GlaxoSmithKline Biologicals. Dr Halpern has received her bachelor’s degree in

With this acquisition, Biotest Pharmaceuticals now operates 11 plasma centers in various locations throughout the US. In 2008, the company announced it had aggressive plans for further expansion

Oral dnaJP1 is a 14 amino acid sequence delivered once daily to rheumatoid arthritis (RA patients). Oral dnaJP1 has completed a 160 patient double-blind, placebo controlled Phase II

According to the company, this position will cover all group’s business development and acquisition activities as well as corporate planning, financial and economic evaluation of internal and external

The patented Falena device is a winged structure manufactured in titanium with a ‘C’ shaped spacer in Peek Optima to extend a rigidity and elasticity similar to bone

Under the brand name Preventa, Sensiotec will market and sell the medical device in the US and Canada under an exclusive worldwide license with its affiliate, Wireless 2000.

The Vitesse intracranial stent study for ischemic therapy (VISSIT) clinical trial is designed to include up to 250 patients who demonstrate ischemic symptoms attributable to stenosis of an

The acquisition of Ovation delivers on Lundbeck’s strategic goal to build a commercial infrastructure in the US. Following the transaction Lundbeck will have a diverse portfolio of marketed

Merck has reported positive data from new subgroup analyses of a Phase III study that compared the company’s integrase inhibitor Isentress to efavirenz, an antiretroviral prescribed for previously